ANI Pharmaceuticals, Inc.ANIPNASDAQ
LOADING
|||
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$614.38M
↑ 133% above average
Average (9y)
$263.21M
Historical baseline
Range
High:$614.38M
Low:$76.32M
CAGR
+26.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $614.38M | +26.2% |
| 2023 | $486.82M | +53.9% |
| 2022 | $316.38M | +46.4% |
| 2021 | $216.14M | +3.7% |
| 2020 | $208.47M | +0.9% |
| 2019 | $206.55M | +2.5% |
| 2018 | $201.58M | +14.0% |
| 2017 | $176.84M | +37.5% |
| 2016 | $128.62M | +68.5% |
| 2015 | $76.32M | - |